Alembic Pharmaceuticals’ Hypertension Pills gets US FDA Approval
Alembic Pharmaceuticals Ltd announced that, Brexpiprazole tablets, which are used to treat schizophrenia and major depressive disorder, have received tentative approval from the United States Food and Drug Administration (FDA). Abbreviated New Drug Application (ANDA) Brexpiprazole Tablets in strengths of 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg have received […]
Continue Reading